Ligand Pharmaceuticals Inc (LGND)

Apr 15, 2026

Travere, Ligand Pharma announce FDA label expansion for Filspari - MSN

Apr 15, 2026

Apr 14, 2026

LGND Maintained by HC Wainwright & Co. -- Price Target Raised to $243 - GuruFocus

Apr 14, 2026

Apr 14, 2026

Ligand (LGND) Partners with Travere on FDA Approval for Filspari - GuruFocus

Apr 14, 2026

Apr 14, 2026

H.C. Wainwright raises Ligand Pharma price target on royalty growth By Investing.com - Investing.com Canada

Apr 14, 2026

Apr 14, 2026

Ligand Pharmaceuticals stock hits 52-week high at 228.09 USD By Investing.com - Investing.com Canada

Apr 14, 2026

Apr 14, 2026

Travere, Ligand win FDA label expansion for Filspari (TVTX) - Seeking Alpha

Apr 14, 2026

Apr 14, 2026

First approved FSGS drug gives Ligand a 9% sales royalty - Stock Titan

Apr 14, 2026

Apr 12, 2026

Free cash flow per share of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ - TradingView — Track All Markets

Apr 12, 2026

Apr 12, 2026

Cash per share of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ - TradingView — Track All Markets

Apr 12, 2026

Apr 10, 2026

TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - Stocktwits

Apr 10, 2026

Apr 09, 2026

S P Trends: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandEntry Point & Comprehensive Market Scan Reports - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Ligand Pharmaceuticals Incorpor (LGND) Stock forecasts - Yahoo Finance UK

Apr 09, 2026

Apr 08, 2026

Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo Finance

Apr 08, 2026

Apr 08, 2026

LGND Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 08, 2026

Apr 08, 2026

Aug Chart Watch: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandTrade Volume Report & Weekly High Return Stock Forecasts - baoquankhu1.vn

Apr 08, 2026

Apr 06, 2026

Tech Rally: Is Ligand Pharmaceuticals Incorporated being accumulated by smart money2026 Momentum & Community Consensus Trade Signals - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 06, 2026

Apr 06, 2026

Ligand Pharmaceuticals Incorporated (LGND) stock price, news, quote and history - Yahoo Finance UK

Apr 06, 2026

Apr 06, 2026

Aberdeen Group plc Lowers Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Apr 06, 2026

Apr 05, 2026

Allspring Global Investments Holdings LLC Has $13.65 Million Position in Ligand Pharmaceuticals Incorporated $LGND - marketbeat.com

Apr 05, 2026

Apr 04, 2026

LGND Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 04, 2026

LGND Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Is Ligand Pharmaceuticals (LGND) Still Attractive After Doubling Over The Past Year - Yahoo Finance

Apr 04, 2026

Apr 03, 2026

EBIT per share of Ligand Pharmaceuticals Incorporated – OTC:LGNYZ - TradingView

Apr 03, 2026

Apr 03, 2026

Ligand Pharmaceuticals director Kozarich sells $94k in stock By Investing.com - Investing.com Australia

Apr 03, 2026

Apr 02, 2026

Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus

Apr 02, 2026

Apr 02, 2026

Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceuticals Inc (LGND) - GuruFocus

Apr 02, 2026

Apr 02, 2026

Ligand Pharmaceuticals (NASDAQ:LGND) Director John Kozarich Sells 467 Shares - MarketBeat

Apr 02, 2026

Apr 02, 2026

Ligand Pharmaceuticals (NASDAQ:LGND) Insider Andrew Reardon Sells 5,000 Shares - MarketBeat

Apr 02, 2026

Apr 02, 2026

Ligand Pharmaceuticals director Kozarich sells $94k in stock - Investing.com

Apr 02, 2026

Apr 02, 2026

Planned sales: Ligand Pharmaceuticals (LGND) director trims 467 shares - Stock Titan

Apr 02, 2026

Apr 02, 2026

Ligand Pharmaceuticals CLO sells $1m in shares By Investing.com - Investing.com India

Apr 02, 2026

Apr 02, 2026

Ligand Pharmaceuticals CLO sells $1m in shares - Investing.com

Apr 02, 2026

Apr 02, 2026

Ligand (NASDAQ: LGND) CLO sells 5,000 shares after exercising stock options - Stock Titan

Apr 02, 2026

Apr 01, 2026

Board member Todd Davis (PTHS) updates Pelthos stock grants and holdings - Stock Titan

Apr 01, 2026

Apr 01, 2026

LGND (NASDAQ: LGND) Rule 144 sales — 467 shares on three dates - Stock Titan

Apr 01, 2026

Apr 01, 2026

Insider Move: John L LaMattina Exercises Options, Realizing $185K At Ligand Pharmaceuticals - Benzinga

Apr 01, 2026

Apr 01, 2026

Ligand Pharmaceuticals (NASDAQ:LGND) Passes Minervini Trend Template and Growth Screen - ChartMill

Apr 01, 2026

Mar 31, 2026

Ligand Pharma CLO Sells $1.03M in Stock | Transaction Details & Company BackgroundNews and Statistics - IndexBox

Mar 31, 2026

Mar 31, 2026

Ligand Pharmaceuticals director LaMattina sells $433k in shares By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

Ligand Pharmaceuticals director LaMattina sells $433k in shares - Investing.com

Mar 31, 2026

Mar 31, 2026

Ligand (NASDAQ: LGND) director exercises options, sells 2,161 common shares - Stock Titan

Mar 31, 2026

Mar 31, 2026

LIGAND PHARMACEUTICALS INCORPORATED (LGND) - MSN

Mar 31, 2026